Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 131-135

  Long, Zaiyang ^a,b   Medlock, Carla ^b   Dzemidzic, Mario ^b   Shin, Yong Wook ^c   Goddard, Andrew W ^b   Dydak, Ulrike ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Family history; GABA; MRS; Panic disorder

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; ANTERIOR CINGULATE; ARTICLE; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MALE; MEDIAL PREFRONTAL CORTEX; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PANIC; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; RATING SCALE;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PANIC DISORDER; PREFRONTAL CORTEX;

EID: 84874784089     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.020     Document Type: Article

References (32)

1. Balon R., Jordan M., Pohl R., Yeragani V.K. Family history of anxiety disorders in control subjects with lactate-induced panic attacks. Am J Psychiatry 1989, 146:1304-1306.
2. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., et al. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 2007, 61:806-812.
3. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000, 4(6):215-222.
4. Cameron O.G., Huang G.C., Nichols T., Koeppe R.A., Minoshima S., Rose D., et al. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch Gen Psychiatry 2007, 64:793-800.
5. Edden R.A., Barker P.B. Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 2007, 58:1276-1282.
6. Finn C.T., Smoller J.W. The genetics of panic disorder. Curr Psychiatry Rep 2001, 3:131-137.
7. Gaudino E.A., Geisler M.W., Squires N.K. Construct validity in the Trail Making Test: what makes Part B harder?. J Clin Exp Neuropsychol 1995, 17:529-535.
8. Goddard A.W., Mason G.F., Almai A., Rothman D.L., Behar K.L., Petroff O.A., et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001, 58:556-561.
9. Goddard A.W., Mason G.F., Rothman D.L., Behar K.L., Petroff O.A., Krystal J.H. Family psychopathology and magnitude of reductions in occipital cortex GABA levels in panic disorder. Neuropsychopharmacology 2004, 29:639-640.
10. Goto N., Yoshimura R., Kakeda S., Moriya J., Hori H., Hayashi K., et al. No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(8):1480-1483.
11. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129-153.
12. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Goldstein R.B., Smith S., et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006, 67:363-374.
13. Ham B.J., Sung Y., Kim N., Kim S.J., Kim J.E., Kim D.J., et al. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:403-411.
14. Hasler G., Nugent A.C., Carlson P.J., Carson R.E., Geraci M., Drevets W.C. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 2008, 65:1166-1175.
15. Hasler G., van der Veen J.W., Geraci M., Shen J., Pine D., Drevets W.C. Prefrontal cortical gamma-aminobutyric acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biol Psychiatry 2009, 65:273-275.
16. Kakeda S., Korogi Y., Moriya J., Ohnari N., Sato T., Ueno S., et al. Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T. Psychiatry Res 2011, 192:55-59.
17. Kaschka W., Feistel H., Ebert D. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiatr Res 1995, 29:427-434.
18. Kugler P. Enzymes involved in glutamatergic and GABAergic neurotransmission. Int Rev Cytol 1993, 147:285-336.
19. Long Z., Murdoch James, Xu J., Dydak U. Proc Intl Soc Magn Reson Med 2011, 19:1399.
20. Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., Nutt D.J. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998, 55:715-720.
21. Massana G., Gasto C., Junque C., Mercader J.M., Gomez B., Massana J., et al. Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy. Neuroimage 2002, 16:836-842.
22. Merikangas K.R. Genetic epidemiologic studies of affective disorders in childhood and adolescence. Eur Arch Psychiatry Clin Neurosci 1993, 243:121-130.
23. Mescher M., Merkle H., Kirsch J., Garwood M., Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998, 11:266-272.
24. Ongur D., Prescot A.P., McCarth J., Cohen B.M., Renshaw P.F. Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiatry 2010, 68(7):667-670.
25. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993, 30:672-679.
26. Schlegel S., Steinert H., Bockisch A., Hahn K., Schloesser R., Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci 1994, 244:49-51.
27. Shear M.K., Brown T.A., Barlow D.H., Money R., Sholomskas D.E., Woods S.W., et al. Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry 1997, 154:1571-1575.
28. Smoller J.W., Gardner-Schuster E., Covino J. The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 2008, 148C:118-126.
29. Trzesniak C., Uchida R.R., Araujo D., Guimaraes F.S., Freitas-Ferrari M.C., Filho A.S., et al. (1)H magnetic resonance spectroscopy imaging of the hippocampus in patients with panic disorder. Psychiatry Res 2010, 182:261-265.
30. Vogt B.A., Finch D.M., Olson C.R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992, 2(6):435-443.
31. Weissman M.M. Family genetic studies of panic disorder. J Psychiatr Res 1993, 27(Suppl. 1):69-78.
32. Weissman M.M., Merikangas K.R. The epidemiology of anxiety and panic disorders: an update. J Clin Psychiatry 1986, 47:11-17. [Suppl.].